Ronald M MD Kurtz's Net Worth
$42.5 Million
Who is Ronald M MD Kurtz?
Ronald M MD Kurtz has an estimated net worth of $42.5 Million. This is based on reported shares across multiple companies, which include INTRALASE CORP, and RxSight, Inc..
SEC CIK
Ronald M MD Kurtz's CIK is 0001295469
Past Insider Trading and Trends
2021 was Ronald M MD Kurtz's most active year for acquiring shares with 3 total transactions. Ronald M MD Kurtz's most active month to acquire stocks was the month of July. 2005 was Ronald M MD Kurtz's most active year for disposing of shares, totalling 20 transactions. Ronald M MD Kurtz's most active month to dispose stocks was the month of June. 2021 saw Ronald M MD Kurtz paying a total of $2,050,378.30 for 467,457 shares, this is the most they've acquired in one year. In 2024 Ronald M MD Kurtz cashed out on 62,500 shares for a total of $2,765,631.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTRALASE CORP No price found
VP, Medical Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.81% | -2.00K |
$19.48 | -$38,960.00 | 243.76K |
Scheduled
|
Aug 8
| ||
Form 4
| -5.75% | -15.00K |
$20.86 | -$312,900.00 | 245.76K |
Scheduled
|
Aug 1
| ||
Form 4
| -2.25% | -6.00K |
$21.99 | -$131,940.00 | 260.76K |
Scheduled
|
Jul 27
| ||
Form 4
| -4.30% | -12.00K |
$18.93 | -$227,120.00 | 266.76K |
Scheduled
|
Jul 25 - Jul 26
| ||
Form 4
| -3.13% | -9.00K |
$18.04 | -$162,400.00 | 278.76K |
Scheduled
|
Jul 18
| ||
Form 4
| -1.03% | -3.00K |
$20.88 | -$62,640.00 | 287.76K |
Scheduled
|
Jul 14
| ||
Form 4
| -3.96% | -12.00K |
$19.89 | -$238,620.00 | 290.76K |
Scheduled
|
Jul 11
| ||
Form 4
| -3.81% | -12.00K |
$19.93 | -$239,197.20 | 302.76K |
Scheduled
|
Jul 5
| ||
Form 4
| -3.67% | -12.00K |
$19.52 | -$234,240.00 | 314.76K |
Scheduled
|
Jun 27
| ||
Form 4
| -2.68% | -9.00K |
$19.15 | -$172,350.00 | 326.76K |
Scheduled
|
Jun 20
| ||
Form 4
| -5.09% | -18.00K |
$19.03 | -$342,480.00 | 335.76K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
| +3.00% | 10.31K |
—
|
—
| 353.76K |
Apr 27 - Oct 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RxSight, Inc. (RXST) Snapshot price: $47.49
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.97% | -40.00K |
$60.15 | -$2,405,872.00 | 764.61K |
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| -7.21% | -62.50K |
$44.25 | -$2,765,631.25 | 804.61K |
Jan 8
| |||
Form 4
| -2.53% | -22.50K |
$41.09 | -$924,498.00 | 867.11K |
Scheduled
|
Dec 27
| ||
Form 4
| -4.30% | -40.00K |
$39.70 | -$1,588,186.00 | 889.61K |
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
∞
| 40K |
$12.50 | $500,000.00 | 40K |
Feb 10
| |||
Form 4
| +16.06% | 128.64K |
$14.93 | $2,050,378.30 | 929.61K |
Aug 3 - Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||